Tunicamycin at 10 #g/ml inhibits the growth and infectivity of the parasitic protozoan Leishmania mexicana amazonensis. Tunicamycin-resistant variants of this parasite were produced by (i) gradual acclimatization of cells to increasing concentrations of the drug up to 80 ,Lg/ml and (ii) a single-step selection of ethyl methanesulfonate-pretreated or differentiating leishmanias with the drug at 10 ,ug/ml. Prolonged exposure to the drug increases stability of drug resistance of those resistant to 10 jig/ml. Tunicamycin We report here our success in producing variants of this parasite resistant to tunicamycin (TM), which inhibits Nacetylglucosamine-1-phosphotransferase in the dolichol pathway of protein glycosylation (4). The TM-resistant cells possess an increased amount of this enzyme, apparently due to gene amplification. They are more virulent than the parental wild type, pointing to the expression of a gene or genes encoding this and possibly other related enzymes as a molecular basis of leishmanial virulence.
Molecular mechanism of virulence remains largely unknown in diseases caused by parasitic protozoa. Glycoproteins on the surface of these parasites are often implicated in their evasion of host immunity or invasion of their host cells to establish parasitism. Since glycosylation of proteins can change their properties and thus their biological functions (1) , molecular regulation of this event in the parasites may be important in considering their virulence.
Leishmania mexicana amazonensis is a trypanosomatid protozoan that causes human cutaneous leishmaniasis. The parasite exists as extracellular promastigotes in the sandfly gut and as intracellular amastigotes in the mammalian macrophages. The glycoconjugates of this and other species on the cell surface or released as excreted factors appear to be important virulent factors in intracellular parasitism of macrophages (2, 3) . One useful approach to study this is to produce leishmanial variants resistant to inhibitors of protein glycosylation.
We report here our success in producing variants of this parasite resistant to tunicamycin (TM), which inhibits Nacetylglucosamine-1-phosphotransferase in the dolichol pathway of protein glycosylation (4) . The TM-resistant cells possess an increased amount of this enzyme, apparently due to gene amplification. They are more virulent than the parental wild type, pointing to the expression of a gene or genes encoding this and possibly other related enzymes as a molecular basis of leishmanial virulence.
MATERIALS AND METHODS
Leishmania and Macrophage. L. mexicana amazonensis (LV78) and the murine macrophage line J774G8 were obtained and grown as described (5) . Promastigotes were cultured at 270C in medium 199 with 25 mM Hepes, pH 7.4, and 10% heat-inactivated fetal bovine serum. Established procedures were followed for the cultivation and isolation of amastigotes (5, 6) .
Treatment of Leishmania with TM. TM (Sigma) was dissolved in 0.01 M NaOH at 1-2 mg/ml. Promastigotes at 5 x 106 cells per ml in the complete medium were treated with TM at 2, 4, 8, and 10 ,ug/ml. Viable promastigotes were counted in a hemacytometer.
Production of Leishmanial Variants Resistant to TM. Promastigotes were made resistant to TM in one of three ways: (i) Stepwise selection. Wild-type cells were gradually acclimatized to grow by increasing concentrations of the drugi.e., 2, 4, 6, 8, 10, 20, 40, 60 , and 80 jig/ml. (ii) Single-step selection of cells pretreated with ethyl methanesulfonate. Wild-type logarithmic-phase promastigotes were treated at 107 cells per ml with ethyl methanesulfonate at 9 mg/ml for 4 hr in the complete culture medium and allowed to grow in ethyl methanesulfonate-free medium for 2 days. Serial dilutions of these cells from 102 to 107 per 100 ,ll were each plated onto the complete culture medium (25 ml per 9-cm Petri dish) containing 1% agar with and without TM at 10 or 80 ,g/ml. Colonies that developed on the agar plates were transferred into liquid medium for further testing their drug sensitivity. (iii) Single-step selection by treating leishmanias during differentiation. Amastigotes isolated from infected macrophages were treated at 27°C with 10 ,ug of TM per ml at 107 cells per ml in the culture medium under conditions for their differentiation into promastigotes.
Variants resistant to TM at 10 ,Ag/ml and produced by methods i, ii, and iii are referred to as "Step 10," "EMS 10," and "Differentiation 10," respectively. Those resistant to 80 ,ug/ml are similarly referred to as "Step 80," etc.
Assay for N-Acetylglucosamine-l-phosphotransferase. N clease A (Sigma) at 50 ,ug/ml and then for 2 hr with proteinase K at 50 ,g/ml in 5 mM EDTA/80 mM NaCl. Subsequent extraction, precipitation, and solubilization of DNA were repeated as described above.
Agarose Gel Electrophoresis of Endonuclease-Digested DNA. DNAs were digested to completion with endonucleases-e.g., BamHI at 5 units/,ug of DNA-and electrophoresed at 1 V/cm in 0.3% agarose containing 80 mM Tris, 80 mM boric acid, 1 mM EDTA, and ethidium bromide (EtdBr) at 0.5 ug/ml (pH 7.8).
Dot-Blot and Southern Hybridization. DNA samples were boiled for 5 min and dot-blotted in serial dilutions onto Zetabind (AMF, Meriden, CT) in the presence of lOx SSC (lx = 150 mM NaCl/15 mM sodium citrate, pH 7.4). Endonuclease-digested DNA electrophoresed in agarose gel was treated with 0.25 M HC (11) and then transferred to Zetabind as described by Southern (12) . Filters were hybridized with the plasmid Alg 7 (13) . pBR322 with this insert in Escherichia coli (DHI) was isolated by the alkaline lysis method (14) and labeled with [a-32P]dATP (New England Nuclear; 3000 Ci/mmol) as described (15) . After hybridization under conditions specified by the manufacturer (AMF) for 16 hr, the filters were washed twice at room temperature for 15 min in 2x SSC with 0.1% NaDodSO4 and then at 60°C
for 30 min twice in 0.lx SSC with 0.1% NaDodSO4. Filters were exposed to Kodak X-Omat film at room temperature or at -80°C with Cronex intensifying screen.
Infection ,ug/ml in a course of several months. During the period of adaptation, the survival rate of cells varied from 0.01% to 75%.
In the single-step selection, promastigotes with or without prior treatment with ethyl methanesulfonate gave comparable plating efficiencies of 4-6 x 10-5 in the agar medium containing TM at 10 gg/ml. However, only the colonies that emerged from ethyl methanesulfonate-pretreated promastigotes grew continuously after transfer to the liquid medium with TM at 10 ,ug/ml. Plating ethyl methanesulfonate-treated promastigotes on agar medium with TM at 80 ,ug/ml yielded no colonies.
Treatment of leishmanias during their differentiation from amastigotes to promastigotes with TM at 10 ,g/ml resulted in degeneration of most cells, except for a small number that 10 ,ug/ml and continuously exposed to the drug for 6 months retained their drug resistance much longer than those preexposed to the drug for only 3 months (Fig. 1) . All those made resistant to 80 ,g/ml were much less stable: continuous exposure of these cells to TM for as long as 18 months allowed them to retain their drug resistance for no more than 3 months under drug-free conditions (Fig. 1) . The loss of drug resistance from these cells appeared to be complete, as the revertants were as sensitive to TM as the wild type.
TM resistance was retained by leishmanias after one cycle of promastigote-amastigote-promastigote differentiation (the amastigote stage being under drug-free conditions) through cultured macrophages for up to 14 days.
N-Acetylglucosanine-l-phosphotransferase Activity of WildType and TM-Resistant Variants. The enzyme activity was linear with the amount of microsomal protein from 50 to 200 ,ug and with reaction times of 0, 5, and 10 min. The microsomal enzymes from both the wild type and all TMresistant cells were almost completely inhibited by TM at 5 ,g/ml, but the uninhibited enzyme activity was about 3-to 5-fold and 10-to 15-fold higher in Mt 10 and Mt 80 than in the wild-type cells (Fig. 2) .
DNA Amplification in TM-Resistant Leishmania Variants. BamHI digests of DNA gave four amplified EtdBr-staining fragments, 12, 14, 15, and 22 kilobase pairs (kbp) long, which were most prominent in Mt 80, less obvious in Mt 10, and unnoticeable in the wild type (Fig. 3) . Southern blot analysis showed that these BamHI fragments of the amplified DNA hybridized to Alg 7 plasmid (Fig. 4A) 6 ,ug/ml, 10 Ag/ml in 1 month, and 10 Iug/ml for longer than 6 months, respectively. hybridization pattern of amplified bands (EMS 10 in Fig. 4A) . However, the same hybridization banding pattern was seen for all Mt 80, including the one produced from EMS 10. Alg 7 hybridized strongly With yeast DNA as expected (Fig. 4A) .
Estimation by dot-blot hybridization using the same probe gave about 30-fold and 100-fold amplifications of the DNA in Mt 10 and Mt 80, respectively, as compared to wild-type cell DNA (Fig. 4B) . The amplified DNA was lost from the drug-sensitive revertants that emerged from TM-resistant cells cultured in the absence of drug (not shown). Virulence of TM-Resistant Leishmanias to Mice. Results from four independent experiments showed that all Mt 10 produced lesions larger than did the parental wild type. Fig.  5 shows the lesions in mice after infection for 159 days from a representative series of such experiments. The diameters of the lesions and the total numbers of amastigotes (mean ± SD) therein produced by Mt 10 were 18.2 ± 1.9 mm and 3.17 ± 0.2 x 109 cells, respectively, whereas those produced by the wild type were 10.5 ± 1.0 mm and 1.4 ± 0.1 x 109 cells, respectively. Early ulceration and metastasis of the lesions were also associated with the TM-resistant parasites. All Mt 80 were less virulent than Mt 10, but were more so than the parental wild type (not shown). The development of the lesion was considerably delayed in mice infected with the wild type pretreated with TM at 10 gg/ml for 12 hr (Fig. SC) .
TM-sensitive revertants were similar to the parental wild type in their virulence to mice (not shown).
DISCUSSION
We show here that a protozoan parasite is more virulent than the parental wild type when made resistant to TM, a known inhibitor of N-acetylglucosamine-1-phosphotransferase in the dolichol pathway for glycosylation of proteins (1) . All isolated TM-resistant variants have an increased activity of the glycosyltransferase and amplified DNA apparently containing the gene encoding this enzyme. Thus, expression of the glycosyltransferase gene may be implicated as the molecular basis of virulence in protozoal infections. The TMresistant variants are of value as another model to study the mechanism of drug-induced DNA amplification. The availability of these variants may also facilitate the isolation and characterization of the enzyme and its gene.
TM was found to inhibit the growth and infectivity of L. mexicana amazonensis, as reported earlier for Leishmania braziliensis (16) and Leishmania donovani (17) . The importance of N-glycosylation of proteins in the cellular functions has been shown in eukaryotic cells (18, 19) .
We produced TM-resistant leishmanias to facilitate analysis of the functional importance of their protein glycosylation. All TM-resistant variants were found to have the Proc. Natl. Acad. Sci. USA 84 (1987) following properties: (i) The activity of the glycosyltransferase is increased with the level of drug resistance but remains sensitive to inhibition by TM. (ii) There is DNA amplification, the degree of which increases with that of the drug resistance. (iii) The amplified DNA hybridizes with Alg 7 plasmid, which apparently contains yeast N-acetylglucosaminyltransferase gene (13) . (iv) TM resistance is initially unstable, but prolonged exposure of cells to appropriate concentrations of the drug improves the stability. (v) Revertants derived from TM-resistant cells after prolonged culture in drug-free medium lose both the amplification of DNA and that of the enzyme activity. These properties of TM-resistant leishmanias are consistent with those described for methotrexate-resistant mammalian cells (20) (21) (22) and leishmanias (23, 24) with amplified dihydrofolate reductase gene. Accordingly, the mechanism of TM resistance developed in L. mexicana amazonensis appears to be an amplification of the gene encoding the glycosyltransferase, which leads to an overproduction of the enzyme, enabling cells to overcome the inhibitory effect of TM. DNA amplification associated with TM-resistant cells has not been reported previously to our knowledge, although this was suggested on the basis of finding an increased activity of the enzyme in CHO cells (25) . Our interpretation can be strengthened further by determining the quantity of the enzyme at the protein level, the structure of its gene, and its expression at the mRNA level.
Southern analysis of leishmania DNAs with Alg 7 plasmid provides some information on the structure of the amplified sequences in TM-resistant cells. Alg 7 in the probe used, originally cloned from yeast DNA, is no more than 4 kbp in size (13) . Transformation of yeasts with plasmids containing DNA complementary to Alg 7 confers TM resistance and increased glycosyltransferase (26 ( Step 80) have been cloned in pBR322; they are linked and share no sequence homology (unpublished data). The possible explanation for the disparity between Alg 7 and the amplified leishmania DNA in size is not yet known.
We found the virulent phenotype associated with all TM-resistant leishmanias produced. DNA amplification with an increase in the activity of the glycosyltransferase found simultaneously in these cells implicates these events in the mechanism of leishmanial virulence. There is a simultaneous loss of virulence and DNA amplification in all lines of drug-sensitive revertants derived from TM-resistant cells.
This suggests strongly that leishmania virulence is linked to the amplified DNA and not to mutation of an unknown gene or genes elsewhere. An increase in the enzyme activity may effect quantitative or qualitative changes in leishmanial glycosylation of proteins, which play important roles in the ability of the parasites to infect macrophages (2) . Gene amplification associated with the virulence of leishmanias is also reminiscent of oncogene amplification found to accompany the expression of neoplastic phenotypes in some cancer cells (27) (28) (29) . Thus, the association of gene amplification with virulence of cells causing diseases of the invasive types may be more common than previously known.
